Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms

Pharmiweb.com RSS Feed Pharmiweb.com RSS Feeds

Advertising

Press Release

Global Axial Spondyloarthritis Treatment Market 2018-2022 - Key Vendors are AbbVie, Amgen, Johnson & Johnson, Pfizer & UCB - ResearchAndMarkets.com

Research and Markets
Posted on: 23 Oct 18

The "Global Axial Spondyloarthritis Treatment Market 2018-2022" report has been added to ResearchAndMarkets.com's offering.

The Global Axial Spondyloarthritis Treatment Market to grow at a CAGR of 7.37% during the period 2018-2022.

Global Axial Spondyloarthritis Treatment Market 2018-2022, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the Key vendors operating in this market. To calculate the market size, the report considers the revenue generated by the sale of drugs for the treatment of axial spondyloarthritis across the globe.

According to the report, one driver influencing this market is the increase in the number of approved biosimilars that is widening the patient base. Considering the high cost of biologics, biosimilars appear as a cost-effective solution and the rise in the number of approved biosimilars will fuel the growth of the global axial spondyloarthritis market during the period of forecast.

One trend affecting this market is the increase in the number of small molecules in the drug development pipeline. Small molecules are generally less expensive than biologics and they are expected to gain traction during the forecast period.

Further, the report states that one challenge affecting this market is the high cost of biologics. Biologics are expensive due to some critical factors such as the high research and development costs and the lengthy testing and manufacturing process which is hindering the growth of the market.

Key vendors

  • AbbVie
  • Amgen
  • Johnson & Johnson
  • Pfizer
  • UCB

Key Topics Covered:

PART 01: EXECUTIVE SUMMARY

PART 02: SCOPE OF THE REPORT

PART 03: RESEARCH METHODOLOGY

PART 04: MARKET LANDSCAPE

PART 05: MARKET SIZING 2017-2022

PART 06: FIVE FORCES ANALYSIS

PART 07: PIPELINE LANDSCAPE

PART 08: MARKET SEGMENTATION BY CATEGORY

  • Comparison by category
  • Global ankylosing spondylitis treatment market
  • Global non-radiographic axial spondyloarthritis treatment market
  • Market opportunity by category

PART 09: CUSTOMER LANDSCAPE

PART 10: REGIONAL LANDSCAPE

  • Geographical segmentation
  • Regional comparison
  • Market opportunity

PART 11: DECISION FRAMEWORK

PART 12: DRIVERS AND CHALLENGES

PART 13: MARKET TRENDS

PART 14: VENDOR LANDSCAPE

  • Overview
  • Landscape disruption

PART 15: VENDOR ANALYSIS

  • Vendors covered
  • Vendor classification
  • Market positioning of vendors

For more information about this report visit https://www.researchandmarkets.com/research/jtq2pl/global_axial?w=4

View source version on businesswire.com: https://www.businesswire.com/news/home/20181023005852/en/

Business Wire
www.businesswire.com

Last updated on: 23/10/2018

Advertising
Site Map | Privacy & Security | Cookies | Terms and Conditions

PharmiWeb.com is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on PharmiWeb.com is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.